PubMed

Physical anhedonia in the acute phase of schizophrenia.

Kontaxakis VP, Kollias CT, Havaki-Kontaxaki BJ, Margariti MM, Stamouli SS, Petridou E, Christodoulou GN.

Ann Gen Psychiatry. 2006 Jan 18;5:1.PMID: 16417645 [PubMed]Related articlesFree article

Association of physical and social anhedonia with depression in the acute phase of schizophrenia.

Kollias CT, Kontaxakis VP, Havaki-Kontaxaki BJ, Stamouli S, Margariti M, Petridou E.

Psychopathology. 2008;41(6):365-70. Epub 2008 Sep 3.PMID: 18765962 [PubMed - indexed for MEDLINE]Related articles

The Greek version of the calgary depression scale for schizophrenia.

Kontaxakis VP, Havaki-Kontaxaki BJ, Margariti MM, Stamouli SS, Kollias CT, Angelopoulos EK, Christodoulou GN.

Psychiatry Res. 2000 May 15;94(2):163-71.PMID: 10808041 [PubMed - indexed for MEDLINE]Related articles

Anhedonia in schizophrenia and major depression: state or trait?

Pelizza L, Ferrari A.

Ann Gen Psychiatry. 2009 Oct 8;8:22.PMID: 19811665 [PubMed - in process]Related articlesFree article

The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.

Plesnicar BK, Zalar B, Breskvar K, Dolzan V.

J Psychopharmacol. 2006 Nov;20(6):829-33. Epub 2006 Feb 14.PMID: 16478753 [PubMed - indexed for MEDLINE]Related articles

Stability and relationships between trait or state anhedonia and schizophrenic symptoms in schizophrenia: a 13-year follow-up study.

Loas G, Monestes JL, Ingelaere A, Noisette C, Herbener ES.

Psychiatry Res. 2009 Apr 30;166(2-3):132-40. Epub 2009 Mar 9.PMID: 19272653 [PubMed - indexed for MEDLINE]Related articles

A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.

Lindenmayer JP, Khan A, Iskander A, Abad MT, Parker B.

J Clin Psychiatry. 2007 Mar;68(3):368-79.PMID: 17388705 [PubMed - indexed for MEDLINE]Related articles

Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.

Dolzan V, Serretti A, Mandelli L, Koprivsek J, Kastelic M, Plesnicar BK.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1562-6. Epub 2008 Jun 24.PMID: 18573584 [PubMed - indexed for MEDLINE]Related articles

Clinical characteristics and associated factors in antipsychotic-induced akathisia of Asian patients with schizophrenia.

Chong SA, Mythily, Remington G.

Schizophr Res. 2003 Jan 1;59(1):67-71.PMID: 12413644 [PubMed - indexed for MEDLINE]Related articles

Polymorphisms in dopamine receptor DRD1 and DRD2 genes and psychopathological and extrapyramidal symptoms in patients on long-term antipsychotic treatment.

Dolzan V, Plesnicar BK, Serretti A, Mandelli L, Zalar B, Koprivsek J, Breskvar K.

Am J Med Genet B Neuropsychiatr Genet. 2007 Sep 5;144B(6):809-15.PMID: 17455212 [PubMed - indexed for MEDLINE]Related articles

Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia.

Gebhardt S, Härtling F, Hanke M, Theisen FM, von Georgi R, Grant P, Mittendorf M, Martin M, Fleischhaker C, Schulz E, Remschmidt H.

Eur Child Adolesc Psychiatry. 2008 Feb;17(1):44-53. Epub 2007 Sep 14.PMID: 17876506 [PubMed - indexed for MEDLINE]Related articles

Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.

Möller HJ, Riedel M, Jäger M, Wickelmaier F, Maier W, Kühn KU, Buchkremer G, Heuser I, Klosterkötter J, Gastpar M, Braus DF, Schlösser R, Schneider F, Ohmann C, Riesbeck M, Gaebel W.

Int J Neuropsychopharmacol. 2008 Nov;11(7):985-97. Epub 2008 May 9.PMID: 18466670 [PubMed - indexed for MEDLINE]Related articles

Cocaine is a Major Risk Factor for Antipsychotic Induced Akathisia, Parkinsonism and Dyskinesia.

Maat A, Fouwels A, de Haan L.

Psychopharmacol Bull. 2008;41(3):5-10.PMID: 18779773 [PubMed - in process]Related articles

[Use of antidepressant drugs in schizophrenic patients with depression]

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French. PMID: 16910628 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 6-week, placebo-controlled studies.

Meltzer HY, Bobo WV, Nuamah IF, Lane R, Hough D, Kramer M, Eerdekens M.

J Clin Psychiatry. 2008 May;69(5):817-29.PMID: 18466043 [PubMed - indexed for MEDLINE]Related articles

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. Epub 2008 Jul 9. French. PMID: 19081451 [PubMed - indexed for MEDLINE]Related articles

[Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder]

György B, Robert K, László C, Andrea J; Ketilept Vizsgáló Munkacsoport.

Neuropsychopharmacol Hung. 2008 Dec;10(5):293-303. Hungarian. PMID: 19419015 [PubMed - indexed for MEDLINE]Related articles

Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.

Hofer A, Rettenbacher MA, Edlinger M, Kemmler G, Widschwendter CG, Fleischhacker WW.

Acta Psychiatr Scand. 2007 Nov;116(5):354-61. Epub 2007 Sep 14.PMID: 17868428 [PubMed - indexed for MEDLINE]Related articles

[Anhedonia and depressive symptomatology among HIV-infected patients with highly active antiretroviral therapies (ANRS-EN12-VESPA)]

Préau M, Bonnet A, Bouhnik AD, Fernandez L, Obadia Y, Spire B; VESPA.

Encephale. 2008 Sep;34(4):385-93. Epub 2007 Oct 24. French. PMID: 18922241 [PubMed - indexed for MEDLINE]Related articles

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.PMID: 16707074 [PubMed - indexed for MEDLINE]Related articlesFree article